Adverse Effects and Safety of Etirinotecan Pegol, a Novel Topoisomerase Inhibitor, In Cancer Treatment: A Systematic Review

Mohamad Samare-Najaf, Ali Samareh, Navid Jamali, Ali Abbasi, Cain C. T. Clark, Majid Jafari Khorchani, Fatemeh Zal

    Research output: Contribution to journalReview articlepeer-review

    14 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Adverse Effects and Safety of Etirinotecan Pegol, a Novel Topoisomerase Inhibitor, In Cancer Treatment: A Systematic Review'. Together they form a unique fingerprint.

    Medicine & Life Sciences